NBRV Nabriva Therapeutics plc

$5.05 -2.51%

187,166 Shares Traded
355,305 Average Volume (last 30 days)

as of April 19, 2018 EST IEX Real-Time Price

Free Newsletter Sign Up

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $109.57 thousand
If Intiated on the First, Shorts Have Realized a Year to Date Return of:20.6%
If Intiated One Month Ago, Shorts Have Realized a Return of:6.31%
If Initiated Five Days ago, Shorts Have Realized a Return of:-2.85%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points.

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 2.3%
Short Interest842.83 thousand
Float36.59 million
Short Ratio2.17
Market Cap$185.42 million
Market Maker ActivityDaily Short Volume


Key events next week - healthcare (SeekingAlpha)
Week In Review: WuXi AppTec Plans $910 Million Shanghai IPO (SeekingAlpha)
Your Daily Pharma Scoop: Esperion Gains On Data, AnaptysBio's ANB020, Tesaro Reports Promising Data (SeekingAlpha)
Nabriva and Roivant team up to commercialize lefamulin in China (SeekingAlpha)
Your Daily Pharma Scoop: Achaogen's Plazomicin, Eiger Provides Update On Llonafarnib, Eleven Biotherapeutics Obtains Funding (SeekingAlpha)
Paratek: A Review Of Progress And Preview Of 2018 (SeekingAlpha)
Premarket analyst action - healthcare (SeekingAlpha)
Nabriva Therapeutics reports FY results (SeekingAlpha)
Achaogen: Don't Bring Just Speedos - The (Un)Importance Of Models (SeekingAlpha)
Why Achaogen Might Not Be A Bargain (SeekingAlpha)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 63%
Insider Percent0.3%

Earnings Stats

PE Ratio -2.14
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $7.06
50 Day Moving Average $5.37
52 Week High $14.1
52 Week Low $4.39

Data provided for free by IEX. Questions? Read the FAQ